These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35185925)

  • 21. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
    Valencia-Pacheco G; Layseca-Espinosa E; Niño-Moreno P; Portales-Pérez DP; Baranda L; Rosenstein Y; Abud-Mendoza C; González-Amaro R
    Scand J Rheumatol; 2006; 35(5):368-78. PubMed ID: 17062437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Arthritis Res Ther; 2024 Jan; 26(1):31. PubMed ID: 38243295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.
    Ramírez-Vélez G; Medina F; Ramírez-Montaño L; Zarazúa-Lozada A; Hernández R; Llorente L; Moreno J
    PLoS One; 2012; 7(7):e41414. PubMed ID: 22859983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.
    Deng Y; Zheng Y; Li D; Hong Q; Zhang M; Li Q; Fu B; Wu L; Wang X; Shen W; Zhang Y; Chang J; Song K; Liu X; Shang S; Cai G; Chen X
    EBioMedicine; 2021 Aug; 70():103477. PubMed ID: 34284174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
    Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential activation of protein kinase C delta and JNK is required for interferon-alpha-induced expression of IFIT4.
    Huang X; Yang N; Ou X; Li D; Wang Z; Xie Q; Chen Y; Lin H; Yin G; Wen F
    Cell Signal; 2008 Jan; 20(1):112-9. PubMed ID: 17933493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
    Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
    Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
    Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
    Karonitsch T; von Dalwigk K; Steiner CW; Blüml S; Steiner G; Kiener HP; Smolen JS; Aringer M
    Arthritis Rheum; 2012 Feb; 64(2):400-8. PubMed ID: 21953607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.
    Davies R; Hammenfors D; Bergum B; Vogelsang P; Gavasso S; Brun JG; Jonsson R; Appel S
    Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
    PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RA
    Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
    J Interferon Cytokine Res; 2017 Jun; 37(6):254-268. PubMed ID: 28256939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
    Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients.
    Sarhan RA; Aboelenein HR; Sourour SK; Fawzy IO; Salah S; Abdelaziz AI
    Discov Med; 2015 Jun; 19(107):419-25. PubMed ID: 26175399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.